NAM European HIV prevention project |
Thank you for visiting NAM's survey.
This survey is part of a programme run by NAM to raise awareness of, and access to, new HIV prevention technologies in Europe. It has three aims:
This survey is targeted at people who provide HIV prevention, treatment or care in Europe, as workers or volunteers. But you do not have to be part of any organisation to answer it, and can do so as an individual concerned with HIV.
For the sake of space, we have not attempted to ask in detail about your knowledge of the effectiveness and availability of every possible HIV prevention option, but we do ask your opinions on a broader range of options towards the end of the survey.
This survey should take about 10 to 20 minutes to fill out. We welcome your participation, as it will help us target advocacy for new HIV prevention technologies in Europe.
The NAM European HIV prevention project aims to expand knowledge of, and advocate for more research into, new HIV prevention options in Europe. As well as this survey, it comprises:
The NAM European HIV Prevention Project is funded by unrestricted educational grants from Gilead Sciences, Merck and ViiV Healthcare. They have had no editorial control over its content.
- To assess current knowledge levels in Europe about new and current HIV prevention options.
- To establish people’s knowledge of the availability of these options.
- To establish people’s attitudes towards these options: are they effective, feasible and cost-effective?
This survey is targeted at people who provide HIV prevention, treatment or care in Europe, as workers or volunteers. But you do not have to be part of any organisation to answer it, and can do so as an individual concerned with HIV.
For the sake of space, we have not attempted to ask in detail about your knowledge of the effectiveness and availability of every possible HIV prevention option, but we do ask your opinions on a broader range of options towards the end of the survey.
This survey should take about 10 to 20 minutes to fill out. We welcome your participation, as it will help us target advocacy for new HIV prevention technologies in Europe.
The NAM European HIV prevention project aims to expand knowledge of, and advocate for more research into, new HIV prevention options in Europe. As well as this survey, it comprises:
- A monthly HIV Prevention News: Europe bulletin.
- A series of monthly educational webinars on HIV prevention research, in partnership with AVAC.
- A project to develop a community consensus statement on treatment as prevention, in partnership with EATG.
The NAM European HIV Prevention Project is funded by unrestricted educational grants from Gilead Sciences, Merck and ViiV Healthcare. They have had no editorial control over its content.